Sectra AB (publ) (SECT-B.ST)
SEK 274.3
(0.94%)
SEK 274.3
(0.94%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 518.49 Million SEK | 13.79% |
| 2022 | 455.65 Million SEK | 18.85% |
| 2021 | 383.38 Million SEK | 9.52% |
| 2020 | 350.07 Million SEK | 18.53% |
| 2019 | 295.34 Million SEK | 25.39% |
| 2018 | 235.54 Million SEK | -1.49% |
| 2017 | 239.1 Million SEK | 19.31% |
| 2016 | 200.4 Million SEK | 21.08% |
| 2015 | 165.51 Million SEK | 10.13% |
| 2014 | 150.29 Million SEK | 17.35% |
| 2013 | 128.07 Million SEK | 49.15% |
| 2012 | 85.86 Million SEK | -17.01% |
| 2011 | 103.46 Million SEK | 1155.8% |
| 2010 | 8.23 Million SEK | -75.91% |
| 2009 | 34.19 Million SEK | 59.69% |
| 2008 | 21.41 Million SEK | -73.13% |
| 2007 | 79.69 Million SEK | 30.27% |
| 2006 | 61.18 Million SEK | -19.24% |
| 2005 | 75.75 Million SEK | 204.17% |
| 2004 | -72.72 Million SEK | -271.16% |
| 2003 | -19.59 Million SEK | 74.46% |
| 2002 | -76.72 Million SEK | -27.55% |
| 2001 | -60.14 Million SEK | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 97.08 Million SEK | -50.65% |
| 2023 Q4 | 202.24 Million SEK | 174.3% |
| 2023 Q3 | 73.72 Million SEK | -58.28% |
| 2023 Q1 | 69.31 Million SEK | -64.78% |
| 2023 FY | 518.49 Million SEK | 13.79% |
| 2023 Q2 | 176.71 Million SEK | 154.95% |
| 2022 Q1 | 64.35 Million SEK | -54.41% |
| 2022 Q3 | 86.95 Million SEK | -19.15% |
| 2022 FY | 455.65 Million SEK | 18.85% |
| 2022 Q2 | 107.56 Million SEK | 67.15% |
| 2022 Q4 | 196.78 Million SEK | 126.3% |
| 2021 Q4 | 141.14 Million SEK | 106.22% |
| 2021 Q1 | 90.08 Million SEK | -45.04% |
| 2021 FY | 383.38 Million SEK | 9.52% |
| 2021 Q2 | 83.71 Million SEK | -7.07% |
| 2021 Q3 | 68.44 Million SEK | -18.24% |
| 2020 Q2 | 89.64 Million SEK | 227.37% |
| 2020 Q1 | 27.38 Million SEK | -77.84% |
| 2020 Q3 | 69.12 Million SEK | -22.89% |
| 2020 Q4 | 163.92 Million SEK | 137.14% |
| 2020 FY | 350.07 Million SEK | 18.53% |
| 2019 FY | 295.34 Million SEK | 25.39% |
| 2019 Q1 | 29.37 Million SEK | -65.51% |
| 2019 Q2 | 42.66 Million SEK | 45.23% |
| 2019 Q3 | 99.73 Million SEK | 133.76% |
| 2019 Q4 | 123.57 Million SEK | 23.9% |
| 2018 Q1 | 46.27 Million SEK | -44.73% |
| 2018 FY | 235.54 Million SEK | -1.49% |
| 2018 Q4 | 85.17 Million SEK | 52.9% |
| 2018 Q3 | 55.7 Million SEK | 15.11% |
| 2018 Q2 | 48.39 Million SEK | 4.58% |
| 2017 Q3 | 51.31 Million SEK | -14.18% |
| 2017 Q4 | 83.71 Million SEK | 63.13% |
| 2017 Q1 | 44.27 Million SEK | -40.81% |
| 2017 Q2 | 59.79 Million SEK | 35.06% |
| 2017 FY | 239.1 Million SEK | 19.31% |
| 2016 Q1 | 32.13 Million SEK | -44.6% |
| 2016 Q3 | 47.11 Million SEK | 1.64% |
| 2016 Q4 | 74.8 Million SEK | 58.77% |
| 2016 Q2 | 46.35 Million SEK | 44.23% |
| 2016 FY | 200.4 Million SEK | 21.08% |
| 2015 Q1 | 31.4 Million SEK | -25.89% |
| 2015 FY | 165.51 Million SEK | 10.13% |
| 2015 Q4 | 58.01 Million SEK | 31.92% |
| 2015 Q2 | 32.12 Million SEK | 2.3% |
| 2015 Q3 | 43.97 Million SEK | 36.9% |
| 2014 FY | 150.29 Million SEK | 17.35% |
| 2014 Q1 | 40.46 Million SEK | -25.26% |
| 2014 Q2 | 35.51 Million SEK | -12.22% |
| 2014 Q4 | 42.37 Million SEK | 32.67% |
| 2014 Q3 | 31.94 Million SEK | -10.07% |
| 2013 Q4 | 54.13 Million SEK | 76.97% |
| 2013 Q3 | 30.59 Million SEK | 3.95% |
| 2013 Q1 | 13.91 Million SEK | -63.01% |
| 2013 Q2 | 29.42 Million SEK | 111.47% |
| 2013 FY | 128.07 Million SEK | 49.15% |
| 2012 Q2 | 23 Million SEK | 455.6% |
| 2012 Q1 | 4.14 Million SEK | -91.15% |
| 2012 FY | 85.86 Million SEK | -17.01% |
| 2012 Q4 | 37.61 Million SEK | 78.23% |
| 2012 Q3 | 21.1 Million SEK | -8.24% |
| 2011 Q2 | 44.85 Million SEK | 594.67% |
| 2011 Q3 | 5.36 Million SEK | -88.04% |
| 2011 Q4 | 46.78 Million SEK | 771.92% |
| 2011 FY | 103.46 Million SEK | 1155.8% |
| 2011 Q1 | 6.45 Million SEK | -0.35% |
| 2010 Q1 | 171 Thousand SEK | -99.15% |
| 2010 Q3 | -5.85 Million SEK | -178.66% |
| 2010 FY | 8.23 Million SEK | -75.91% |
| 2010 Q4 | 6.48 Million SEK | 210.71% |
| 2010 Q2 | 7.44 Million SEK | 4251.46% |
| 2009 Q4 | 20.15 Million SEK | 917.44% |
| 2009 FY | 34.19 Million SEK | 59.69% |
| 2009 Q1 | 10.06 Million SEK | 0.0% |
| 2009 Q2 | 6.44 Million SEK | -35.99% |
| 2009 Q3 | -2.46 Million SEK | -138.28% |
| 2008 FY | 21.41 Million SEK | -73.13% |
| 2007 FY | 79.69 Million SEK | 30.27% |
| 2006 FY | 61.18 Million SEK | -19.24% |
| 2005 FY | 75.75 Million SEK | 204.17% |
| 2004 FY | -72.72 Million SEK | -271.16% |
| 2003 FY | -19.59 Million SEK | 74.46% |
| 2002 FY | -76.72 Million SEK | -27.55% |
| 2001 FY | -60.14 Million SEK | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Acarix AB (publ) | -77.55 Million SEK | 768.563% |
| ADDvise Group AB (publ) | 300.6 Million SEK | -72.485% |
| ADDvise Group AB (publ) | 300.6 Million SEK | -72.485% |
| Arcoma AB | 4.66 Million SEK | -11026.416% |
| Bactiguard Holding AB (publ) | -131.93 Million SEK | 492.996% |
| BICO Group AB (publ) | -618.3 Million SEK | 183.858% |
| Boule Diagnostics AB (publ) | 39.27 Million SEK | -1220.323% |
| CellaVision AB (publ) | 167.05 Million SEK | -210.379% |
| Clinical Laserthermia Systems AB (publ) | -65.93 Million SEK | 886.391% |
| Chordate Medical Holding AB (publ) | -29.57 Million SEK | 1853.343% |
| C-Rad AB (publ) | 44.24 Million SEK | -1071.89% |
| Duearity AB (publ) | -25.76 Million SEK | 2112.541% |
| Dignitana AB (publ) | -15.02 Million SEK | 3550.626% |
| Episurf Medical AB (publ) | -94.8 Million SEK | 646.931% |
| Getinge AB (publ) | 3.81 Billion SEK | 86.406% |
| Scandinavian Real Heart AB (Publ) | -68.44 Million SEK | 857.52% |
| Iconovo AB (publ) | -45.77 Million SEK | 1232.651% |
| Integrum AB (publ) | 6.51 Million SEK | -7861.67% |
| Luxbright AB (publ) | -25.8 Million SEK | 2109.309% |
| Mentice AB (publ) | -679 Thousand SEK | 76460.972% |
| OssDsign AB (publ) | -91.95 Million SEK | 663.847% |
| Paxman AB (publ) | 12.61 Million SEK | -4008.812% |
| Promimic AB (publ) | -9.11 Million SEK | 5786.455% |
| Qlife Holding AB (publ) | -168.69 Million SEK | 407.35% |
| SciBase Holding AB (publ) | -53.93 Million SEK | 1061.254% |
| ScandiDos AB (publ) | -13.48 Million SEK | 3945.517% |
| Sedana Medical AB (publ) | -65.54 Million SEK | 891.022% |
| Senzime AB (publ) | -133.74 Million SEK | 487.671% |
| SpectraCure AB (publ) | -21.35 Million SEK | 2528.416% |
| Stille AB | 44.95 Million SEK | -1053.433% |
| Vitrolife AB (publ) | -3.58 Billion SEK | 114.447% |
| Xvivo Perfusion AB (publ) | 38.5 Million SEK | -1246.52% |